<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Avalanche Biotech</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Sun, 07 Jun 2026 09:27:31 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>Avalanche Biotechnologies Gen-Therapie</title>
<link>http://www.aktiencheck.de/forum/Avalanche_Biotechnologies_Gen_Therapie-A1189V-t523085</link>
<guid>http://www.aktiencheck.de/forum/Avalanche_Biotechnologies_Gen_Therapie-A1189V-t523085</guid>
<description>Avalanche Biotechnologies Gen-Therapie, Corporate Profile

Avalanche is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases. Using a next generation gene therapy platform, the Ocular BioFactory™, the Company is developing products designed to provide long-term benefit or a functional cure by inducing a sustained expression of a therapeutic protein with a one-time administration in the eye.
http://www.avalanchebiotech.com/index.php 

Pipeline
http://www.avalanchebiotech.com/pipeline. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Avalanche_Biotechnologies_Gen_Therapie-A1189V-t523085&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







